Abstract:CART (Cocaine- and Amphetamine-Regulated Transcript) peptide is a neurotransmitter naturally occurring in the CNS and found mostly in nucleus accumbens, ventrotegmental area, ventral pallidum, amygdalae and striatum, brain regions associated with drug addiction. In the nucleus accumbens, known for its significant role in motivation, pleasure, reward and reinforcement learning, CART peptide inhibits cocaine and amphetamine-induced dopamine-mediated increases in locomotor activity and behavior, suggesting a CART peptide interaction with the dopaminergic system. Thus in the present study, we examined the effect of CART (55-102) peptide on the basal, electrical field stimulation-evoked (EFS-evoked) (30V, 2Hz, 120 shocks) and returning basal dopamine (DA) release and on the release of the DA metabolites 3,4-dihydroxyphenyl acetaldehyde (DOPAL), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 3,4-dihydroxyphenylethanol (DOPET), 3-methoxytyramine (3-MT) as well as on norepinephrine (NE) and dopamine-o-quinone (Daq) in isolated mouse nucleus accumbens, in a preparation, in which any CART peptide effects on the dendrites or soma of ventral tegmental projection neurons have been excluded. We further extended our study to assess the effect of CART (55-102) peptide on basal cocaine-induced release of dopamine and its metabolites DOPAL, DOPAC, HVA, DOPET and 3-MT as well as on NE and Daq. To analyze the amount of [3H]dopamine, dopamine metabolites, Daq and NE in the nucleus accumbens superfusate, a high-pressure liquid chromatography (HPLC), coupled with electrochemical, UV and radiochemical detections was used. CART (55-102) peptide, 0.1μM, added alone, exerted: (i) a significant decrease in the basal and EFS-evoked levels of extracellular dopamine (ii) a significant increase in the EFS-evoked and returning basal levels of the dopamine metabolites DOPAC and HVA, major products of dopamine degradation and (iii) a significant decrease in the returning basal levels of DOPET. At the same concentration, 0.1μM, CART (55-102) peptide did not have any effect on the release of noradrenaline. In the presence of CART (55-102) peptide, 0.1μM, the effect of cocaine, 30μM, on the basal dopamine release was inhibited and the effect on the basal DOPAC release substantially increased. To our knowledge, our findings are the first to show direct neurochemical evidence that CART (55-102) peptide plays a neuromodulatory role on the dopaminergic reward system by decreasing dopamine in the mouse nucleus accumbens and by attenuating cocaine-induced effects on dopamine release.

Cocaine‐ and Amphetamine‐regulated Transcript Peptide in the Nucleus Accumbens Shell Inhibits Cocaine‐induced Locomotor Sensitization to Transient Over‐expression of Α‐ca2+/calmodulin‐dependent Protein Kinase II

Inhibitory Modulation of CART Peptides in Accumbal Neuron Through Decreasing Interaction of CaMKIIα with Dopamine D3 Receptors.

Microinjection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens inhibits the cocaine-induced upregulation of dopamine receptors and locomotor sensitization.

Decreased Caffeine-Induced Locomotor Activity Via Microinjection of CART Peptide into the Nucleus Accumbens is Linked to Inhibition of the Pcamkiia-D3r Interaction

Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens

A New Insight into the Role of CART in Cocaine Reward: Involvement of CaMKII and Inhibitory G-Protein Coupled Receptor Signaling

Predominant D1Receptors Involvement in the Over-expression of CART Peptides after Repeated Cocaine Administration

Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression

Expression and Activity of Cocaine- and Amphetamine-Regulated Transcript Peptide(1-39) in the Rat

Caffeine Induces Behavioural Sensitization and Overexpression of Cocaine-Regulated and Amphetamine-Regulated Transcript Peptides in Mice.

Cocaine- and Amphetamine-Regulated Transcript Peptide-Immunoreactivity in Dorsal Motor Nucleus of the Vagus Neurons of Immature Rats.

Roles of Cocaine- and Amphetamine-Regulated Transcript in the Central Nervous System

The CaMKII‐dependent Phosphorylation of GABAB Receptors in the Nucleus Accumbens Was Involved in Cocaine‐induced Behavioral Sensitization in Rats

Neuroprotective Mechanislr of Cocaine-and Mnphetane-Wgulated Transcript Peptides in Brain Ischemia

Regulatory role of neuron-restrictive silencing factor in the specific expression of cocaine- and amphetamine-regulated transcript gene.

Cocaine- and Amphetamine-Regulated Transcript Protects Synaptic Structures in Neurons after Ischemic Cerebral Injury.

Protective Effect of Cocaine-and Amphetamine-Regulated Transcript Peptide in Ischemic Brain Injury

Cocaine-and Amphetamine-Regulated Transcript Modulates Peripheral Immunity and Protects Against Brain Injury in Experimental Stroke

CART Modulates Beta-Amyloid Metabolism-Associated Enzymes and Attenuates Memory Deficits in APP/PS1 Mice

Effects of Caffeine on CART Peptide Expressions in Cerebral Striatum of Mice

Effects of Cocain and amphetamine-regulated transcript peptides on ischemic brain damage and Caspase-3 activity of neurons